Table 1. Mean (±SD) 100 kJ (23.9 Kcal) cycling time trial results for supplementation with sodium phosphate (SP) or placebo (PL) 1 and 8 days post-loading (n = 10).
100 kJ (23.9 Kcal) |
SP Day 1 |
SP Day 8 |
PL Day 1 |
PL Day 8 |
Time to Completion (s) |
214.5 (34.6) |
211.9 (33.3) |
216.8 (35.9) |
209.2 (38.1) |
Average Power (W) |
479 (85) |
482 (75) |
473 (79) |
492 (87) |
Heart Rate post (bpm) |
178 (10) |
177 (7) |
175 (7) |
175 (8) |
Rating of Perceived Exertion |
18 (2) |
18 (2) |
18 (2) |
18 (2) |
Blood Lactate Post (mmol·L-1) |
9.1 (1.2) |
9.3 (2.8) |
9.0 (2.0) |
9.4 (2.4) |
Peak VO2 (Oxygen uptake; L·min-1) |
5.08 (.39) |
5.21 (.37) |
5.03 (.35) |
5.12 (.31) |
1st min VO2 (L·min-1) |
2.95 (.37) a (d = .47; 82/15/3 SWC) |
3.14 (.43) |
2.88 (.33) |
2.86 (.50) a (d = 0.60; 88/10/2 SWC) |
Ave VO2 (L·min-1) |
3.75 (.22) a (d = .84; 90/8/3 SWC) |
3.94 (.23) |
3.74 (.18) |
3.77 (.21) a (d = 0.77; 93/6/1 SWC) |
1st min VE (Ventilation expired; L) |
82.5 (21.8) |
82.5 (13.8) |
80.3 (15.7) |
76.3 (18.9) a (d = 0.37; 80/18/2 SWC) |
Ave VE (L) |
123.6 (15.6) |
124.3 (10.4) |
121.0 (10.7) |
122.3 (15.8) |
a = compared with SP8: = effect sizeSWC = smallest worthwhile change probability.